Advertisement
Corrigendum
Open Access |
10.1172/JCI210814
Find articles by Wang, P. in: PubMed | Google Scholar
Find articles by You, N. in: PubMed | Google Scholar
Find articles by Teng, Y. in: PubMed | Google Scholar
Find articles by Lv, Y. in: PubMed | Google Scholar
Find articles by Tian, W. in: PubMed | Google Scholar
Find articles by Xu, J. in: PubMed | Google Scholar
Find articles by Xie, R. in: PubMed | Google Scholar
Find articles by Wu, J. in: PubMed | Google Scholar
Find articles by Yue, G. in: PubMed | Google Scholar
Find articles by Cheng, P. in: PubMed | Google Scholar
Find articles by Zhang, J. in: PubMed | Google Scholar
Find articles by Peng, L. in: PubMed | Google Scholar
Find articles by Mao, F. in: PubMed | Google Scholar
Find articles by Luo, S. in: PubMed | Google Scholar
Find articles by Yang, S. in: PubMed | Google Scholar
Find articles by Zhao, Y. in: PubMed | Google Scholar
Find articles by Zhou, H. in: PubMed | Google Scholar
Find articles by
Chen, W.
in:
PubMed
|
Google Scholar
|
Find articles by
Wang, B.
in:
PubMed
|
Google Scholar
|
Find articles by
Zhuang, Y.
in:
PubMed
|
Google Scholar
|
Published August 17, 2026 - More info
Bacteria-modulated gastric epithelial cells (GECs) play key roles in Helicobacter pylori–associated pathology. Here, we demonstrate both procolonization and proinflammation roles of GEC-derived PPFIA4 in H. pylori infection. PPFIA4 was elevated in GECs from gastric mucosa of H. pylori–infected patients and mice. PPFIA4 could be synergistically induced by H. pylori and IL-33 via the CagA/AP1 pathway. Human gastric PPFIA4 correlated with H. pylori colonization and the severity of gastritis, and H. pylori colonization and inflammation were attenuated in Ppfia4ΔGEC mice. Mechanistically, PPFIA4’s SAM1 domain bound domains from CaMK to the first L27 of CASK and subsequently formed a PPFIA4/CASK/AKT1 complex to activate AKT1, resulting in NF-κB activation and MMP1/CXCL3 secretion. This not only led to decreased E-cadherin and ZO-1 by MMP1, thereby promoting gastric mucosal damage to foster H. pylori colonization, but also resulted in increased gastric influx of G-MDSCs via CXCL3-dependent migration, thereby promoting gastritis and impairing H. pylori–specific IFN-γ–producing CD4+ T cell responses to foster H. pylori colonization. Furthermore, we identified a PPFIA4 inhibitor, kira6, which effectively inhibited GEC’s MMP1/CXCL3 production and ameliorated gastric H. pylori colonization and gastritis. Overall, PPFIA4 could be a promising therapeutic target, as it collectively ensures H. pylori persistence and promotes gastritis.
Pan Wang, Nan You, Yong-Sheng Teng, Yi-Pin Lv, Wen-Qing Tian, Jing-Yu Xu, Rui Xie, Jiang-Bo Wu, Geng-Yu Yue, Ping Cheng, Jin-Yu Zhang, Liu-Sheng Peng, Fang-Yuan Mao, Shou-Lu Luo, Shi-Ming Yang, Yong-Liang Zhao, Hong Zhou, Weisan Chen, Bin Wang, Yuan Zhuang
Original citation: J Clin Invest. 2026;136(9):e193848. https://doi.org/10.1172/JCI193848
Citation for this corrigendum: J Clin Invest. 2026;136(16):e210814. https://doi.org/10.1172/JCI210814
Following the publication of this article, the corresponding author’s institution required all researchers to conduct a self-inspection of publications from the past 3 years. During this process, the authors identified errors in Supplemental Figure 8B, Supplemental Figure 25H, and Supplemental Figure 28 due to errors in referencing calculation formulas or mistakes in pasting the data. The authors have corrected the figures and supporting data values online. The authors haves stated that these errors do not alter the conclusions of the study.
The authors regret the errors.